Boothbay Fund Management’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
IAM
N
PHP
SSA
Boothbay Fund Management's PGEN Position: Q1 2025 in Review
Boothbay Fund Management sold out of Precigen (PGEN) in Q1 2025, closing a stake of 31,607 shares — an estimated $35.4K sold.
Boothbay Fund Management first reported a position in PGEN in Q1 2022 and held it in 3 quarters. The position peaked at $36K in Q1 2022. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.
- Boothbay Fund Management reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
- Boothbay Fund Management sold 31,607 Precigen shares in Q1 2025, an estimated $35.4K.
- Boothbay Fund Management first reported a position in Precigen in Q1 2022 and held it in 3 quarters.
- Boothbay Fund Management's Precigen position peaked at $36K in Q1 2022.
- 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.
Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.